A new study at Washington University School of Medicine in St. Louis may help explain how excess weight can contribute to diabetes and may provide researchers with a target to help prevent or delay diabetes in some of those at risk.
Researchers have tested an artificial pancreas for use by type 2 diabetes patients. The device, which was powered by an algorithm developed at the University of Cambridge, compared to standard treatment, patients spent twice as much time in the glucose target range and half as much time expe
Machine learning techniques can predict with certainty the likelihood that patients with type 2 diabetes would have poor glycemic control. The length of type 2 diabetes, previous glucose levels, and the patient's use of anti-diabetic medications are the most crucial variables influencing gly
One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study led by investigators at Cedars-Sinai.
According to researchers, positive results came from a unique cell treatment experiment for adults with diabetes. A novel cell therapy for the treatment of persons with type 2 diabetes who have progressive kidney impairment despite receiving the best medical care.
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con
Researchers have released encouraging findings from a recent cell therapy experiment for diabetics. The potential of a new cell therapy for treating adults with type 2 diabetes and increasing kidney damage despite receiving the best medical care.
According to a new study using data from the National Institutes of Health's All of Us Research Program published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism, wearable fitness devices provide new insights into the link between physical activity and type 2 di
According to a recent analysis of data from more than 200 countries and regions, type 2 diabetes rates among adolescents and young people have dramatically grown globally between 1990 and 2019.
Type 2 diabetes rates in adolescents and young adults worldwide have increased significantly between 1990 and 2019, according to a new review of data from over 200 nations and regions published in The BMJ today.
A new study proposes a novel strategy to treat type 2 diabetes, putting individuals in command of their own medicine. The Trimaster study is the first to allow persons with type 2 diabetes to choose their own medicine following a series of three different drugs. It came to the conclusion tha
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published tod